- BMO Capital updates IBM (NYSE:IBM) rating to “Market Perform” with a neutral outlook.
- IBM’s earnings per share (EPS) expected to decrease to $1.43 from $1.68.
- Projected quarterly revenue slightly down at $14.39 billion from $14.46 billion.
International Business Machines Corporation, known as IBM, is a major player in the technology industry, listed on the New York Stock Exchange under the symbol IBM. The company is renowned for its hardware, software, and services, with a focus on innovation and technology solutions. IBM faces competition from other tech giants like Microsoft and Oracle.
On April 23, 2025, BMO Capital updated its rating for IBM (NYSE:IBM) to “Market Perform,” maintaining a “hold” action. At this time, IBM’s stock price was approximately $247.65. This rating suggests that BMO Capital expects IBM’s stock to perform in line with the market, indicating a neutral stance on the company’s future performance.
IBM is set to release its first-quarter earnings results after the closing bell on April 22. Analysts expect earnings of $1.43 per share, a decrease from $1.68 per share in the same period last year. This decline in earnings per share (EPS) may have influenced BMO Capital’s decision to maintain a “hold” rating, as it reflects a potential challenge in IBM’s profitability.
The company’s projected quarterly revenue is $14.39 billion, slightly down from $14.46 billion a year earlier. This minor decrease in revenue suggests that IBM is facing some headwinds in maintaining its sales growth. Despite this, IBM’s recent launch of the IBM z17 mainframe, which integrates advanced artificial intelligence features, demonstrates the company’s commitment to innovation and enhancing business operations.
Ahead of the earnings release, IBM shares experienced a 2% increase, closing at $240.90 on Tuesday. This rise in stock price indicates investor optimism about the company’s future prospects, possibly driven by the anticipation of the new mainframe’s impact on IBM’s business. However, the upcoming earnings report will provide more clarity on IBM’s financial health and future direction.
